Details for New Drug Application (NDA): 208912
✉ Email this page to a colleague
The generic ingredient in DEXYCU KIT is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for 208912
Tradename: | DEXYCU KIT |
Applicant: | Eyepoint Pharms |
Ingredient: | dexamethasone |
Patents: | 5 |
Pharmacology for NDA: 208912
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 208912
Suppliers and Packaging for NDA: 208912
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912 | NDA | EyePoint Pharmaceuticals US, Inc | 71879-001 | 71879-001-01 | 1 VIAL, GLASS in 1 CARTON (71879-001-01) / .5 mL in 1 VIAL, GLASS |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;INTRAOCULAR | Strength | 9% | ||||
Approval Date: | Feb 9, 2018 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Jun 22, 2034 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF POSTOPERATIVE INFLAMMATION | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | May 23, 2034 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TREATMENT OF POSTOPERATIVE INFLAMMATION | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | May 23, 2034 | Product Flag? | Y | Substance Flag? | Delist Request? |
Expired US Patents for NDA 208912
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | ⤷ Sign Up | ⤷ Sign Up |
Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription